Cas:71066-00-7 n-boc-2-aminoindane-2-carboxylic acid manufacturer & supplier

Chemical Name:n-boc-2-aminoindane-2-carboxylic acid

CAS.NO:71066-00-7

Synonyms:BOC-AIC-OH;2-Methyl-2-propanyl 3-oxo-9-azabicyclo[3.3.1]nonane-9-carboxylate;2-({[(2-Methyl-2-propanyl)oxy]carbonyl}amino)-2-indanecarboxylic acid;Boc-2-amino-2-indancarboxylic acid;tert-Butyl 3-oxo-9-azabicyclo[3.3.1]nonane-9-carboxylate;2-tert-butoxycarbonylamino-indan-2-carboxylic acid;BOC-2-AIC;RARECHEM EM WB 0049;BOC-AIC;9-Azabicyclo[3.3.1]nonane-9-carboxylic acid, 3-oxo-, 1,1-dimethylethyl ester;Boc-2-Aminoindane-2-carboxylic acid-OH;BOC-2-AMINOINDANE-2-CARBOXYLIC ACID;2-BOC-AMINO-INDAN-2-CARBOXYLIC ACID;N-Boc-9-azabicyclo[3.3.1]nonan-3-one;1H-Indene-2-carboxylic acid, 2-[[(1,1-dimethylethoxy)carbonyl]amino]-2,3-dihydro-

Molecular Formula:C₁₅H₁₉NO₄

Molecular Weight:277.316

HS Code:2924299090

Physical and Chemical Properties:

Melting point:N/A

Boiling point:456.6±45.0 °C at 760 mmHg

Density:1.2±0.1 g/cm3

Index of Refraction:1.568

PSA:75.63000

Exact Mass:277.131409

LogP:3.13

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like BOC-AIC-OH chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,1H-Indene-2-carboxylic acid, 2-[[(1,1-dimethylethoxy)carbonyl]amino]-2,3-dihydro- physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Boc-2-Aminoindane-2-carboxylic acid-OH Use and application,BOC-2-AMINOINDANE-2-CARBOXYLIC ACID technical grade,usp/ep/jp grade.

Related News: Rigosertib, in its intravenous formulation, is currently in Phase 3 clinical development for the treatment of higher-risk MDS. n-boc-2-aminoindane-2-carboxylic acid manufacturer Compared to white women, Black women are more likely to be diagnosed with breast cancer before age 50 or with estrogen receptor (ER)-negative and triple-negative breast cancer. n-boc-2-aminoindane-2-carboxylic acid supplier ��We believe the iLet Bionics Pancreas System represents a true breakthrough therapy for the management of glycemia, particularly in type 1 diabetes,�� said Ed Damiano, President and CEO of Beta Bionics. ��We are partuclarly excited by the possibility that the iLet may be able to provide safer and more effective therapy in far more people than current therapies due to its simplicity of use.�� n-boc-2-aminoindane-2-carboxylic acid vendor ��We believe the iLet Bionics Pancreas System represents a true breakthrough therapy for the management of glycemia, particularly in type 1 diabetes,�� said Ed Damiano, President and CEO of Beta Bionics. ��We are partuclarly excited by the possibility that the iLet may be able to provide safer and more effective therapy in far more people than current therapies due to its simplicity of use.�� n-boc-2-aminoindane-2-carboxylic acid factory Lilly spokesperson Kathryn Beiser and a Justice Department spokesperson declined to comment. Clark did not respond to a request for comment. A Covington spokesperson did not respond to a request for comment nor to a request for a copy of the firm’s report.